JNJ - Johnson & Johnson Profile, Stock Quotes, Financial Analysis, Charts, Fundamentals

Company Name or Ticker Symbol

Search for other Categories

Johnson & Johnson (JNJ)

Other Ticker:

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Price: $129.6600 $0.57

0.442%

Day's High:	$ 130.01	Week Perf:	1.08 %
Day's Low:	$ 129.50	30 Day Perf:	0.4 %
Volume (M):	1,972	52 Wk High:	$ 148.99
Volume (M$):	$ 255,628	52 Wk Avg:	$ 132.33
Open:	$ 129.90	52 Wk Low:	$ 118.62

JNJ Charts & Quotes

You need to upgrade your Flash Player

Description of Company's Segments

Market Capitalization (Millions $)	353,661
Shares Outstanding (Millions)	2,728
Employees	126,500
Revenues (TTM) (Millions $)	81,382
Net Income (TTM) (Millions $)	1,542
Cash Flow (TTM) (Millions $)	335
Capital Exp. (TTM) (Millions $)	3,592

Johnson & Johnson
Johnson & Johnson, is engaged in the manufacture and sale of a broad range of products in the health care field. Through over 200 operating companies, it conducts business in virtually all countries of the world. Johnson & Johnson's primary interest, both historically and currently, has been in products related to human health and well-being. Johnson & Johnson was organized in the State of New Jersey in 1887.

JNJ is expected to report next financial results on January 21, 2019.

Johnson & Johnson's Segments


PROCRIT	Segment	3.06 %	of total Revenue
RISPERDAL	Segment	2.82 %	of total Revenue
REMICADE	Segment	18.37 %	of total Revenue
VELCADE	Segment	3.84 %	of total Revenue
CONCERTA	Segment	2.42 %	of total Revenue
INVEGA	Segment	1.8 %	of total Revenue
Other	Segment	9.08 %	of total Revenue
Total Pharmaceutical	Segment	44.67 %	of total Revenue
Med. Dev. & Diag.	Segment	35.75 %	of total Revenue
Nutritionals	Segment	5.48 %	of total Revenue
Skin Care	Segment	5.03 %	of total Revenue
Total Consumer	Segment	19.58 %	of total Revenue

• View Complete Report

	Company Estimates
	• Revenue Outlook Johnson & Johnson does not provide revenue guidance. • Earnings Outlook Johnson & Johnson issued annual earnings guidance on Oct. 13, 2015

Geographic Revenue Dispersion
United States	46.79 %
Europe	25.49 %
Asia Pacific	18.08 %
Other	9.63 %

News

Leisure Acquisition Corp.

announced third quarter operating deficit of $-0.248187 millions

In the third quarter losses widen of $-0.05 per share compare to $-0.01 a year ago and from $-0.05 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Gordon Pointe Acquisition Corp.

announced third quarter operating deficit of $-0.17028 millions

In the third quarter losses widen of $-0.02 per share compare to $0.00 a year ago and from $-0.02 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Strategic Acquisitions Inc

Logged a Loss but Revenues Unchanged

In the third quarter lost money of $-0.01 per share compare to $-0.03 a year ago and from $-0.01 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Midatech Pharma Plc

Sales and Earnings Unchanged

In the forth quarter reached break-even of $0.00 per share compare to $0.00 a year ago and from $0.00 per share from the previous quarter.

Sales remained unchanged by 0 % to $14.27 millions from $14.27 millions in the same quarter a year ago and sequentially from $0.00 millions.

Enochian Biosciences Inc

announced first quarter operating deficit of $-3.766026 millions

In the first quarter increased losses of $-0.06 per share compare to $0.00 a year ago and eps fell from $0.07 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $14.27 millions in the same quarter a year ago and sequentially from $0.00 millions.

JNJ's Valuation	Current
Price to Earnings PE Ratio (TTM)	219.46
Price to Earnings PE Ratio (Expected)	21.00
Price to Sales (TTM)	4.35
Price to Sales (Expected)	-
Price to Book	5.47
PEG (TTM)	-

JNJ's Financial Strength	Current
Quick Ratio	1.03
Working Capital Ratio	2.52
Leverage Ratio (MRQ)	1.27
Total Debt to Equity	0.48
Interest Coverage (TTM)	24.81
Debt Coverage (TTM)	0.78

Per Share	Current
Earnings (TTM)	0.59 $
Revenues (TTM)	29.84 $
Cash Flow (TTM)	0.12 $
Cash	7.1 $
Book Value	23.69 $
Dividend (TTM)	3.48 $

JNJ's Efficiency	Current
Revenue per Employee (TTM)	643,336
Net Income per Employee (TTM)	12,190
Receivable Turnover Ratio (TTM)	5.83
Inventory Turnover Ratio (TTM)	3.1
Asset Turnover Ratio (TTM)	0.52

JNJ's Profitability Ratio	Current
Gross Margin	67.62 %
Operating Margin	22.09 %
Net Margin	19.33 %
Net Cash Flow Margin	-
Effective Tax Rate (TTM)	91.16 %

Management Effectiveness	Current
Return On Assets (TTM)	0.99 %
Return On Investment (TTM)	1.2 %
Return On Equity (TTM)	2.46 %
Dividend Yield	2.78 %
Payout Ratio (TTM)	589.01 %

JNJ's Valuation
Price to Earnings PE Ratio (TTM)	219.46
Price to Earnings PE Ratio (Expected)	21.00
Price to Sales (TTM)	4.35
Price to Sales (Expected)	-
Price to Book	5.47
PEG (TTM)	-

JNJ's Financial Strength
Quick Ratio	1.03
Working Capital Ratio	2.52
Leverage Ratio (MRQ)	1.27
Total Debt to Equity	0.48
Interest Coverage (TTM)	24.81
Debt Coverage (TTM)	0.78

Per Share
Earnings (TTM)	0.59 $
Revenues (TTM)	29.84 $
Cash Flow (TTM)	0.12 $
Cash	7.1 $
Book Value	23.69 $
Dividend (TTM)	3.48 $

• View Valuation Comparisons

• View Growth Rates Comparisons

JNJ's Efficiency
Revenue per Employee (TTM)	643,336
Net Income per Employee (TTM)	12,190
Receivable Turnover Ratio (TTM)	5.83
Inventory Turnover Ratio (TTM)	3.1
Asset Turnover Ratio (TTM)	0.52

JNJ's Profitability Ratio
Gross Margin	67.62 %
Operating Margin	22.09 %
Net Margin	19.33 %
Net Cash Flow Margin	-
Effective Tax Rate (TTM)	91.16 %

Management Effectiveness
Return On Assets (TTM)	0.99 %
Return On Investment (TTM)	1.2 %
Return On Equity (TTM)	2.46 %
Dividend Yield	2.78 %
Payout Ratio (TTM)	589.01 %

• View Efficiency Comparisons

• View Profitability Comparisons

• View Management Effectiveness

Customers Net Income grew by	JNJ's customers Net margin grew to
19.11 %	4.28 %

• Customers Performance

• Customers Expend.

• Customers Efficiency

• List of Customers

You need to upgrade your Flash Player

Reports on Competition

List of Competitors

Competitors by Segment

Segment Growth

Growth Rates

Suppliers At a Glance

List of Suppliers

Suppliers Performance

Major Competitors

Stock performance

5 Days	Decrease / Increase

PFE	-0.73%
MRK		1.32%
LLY	-0.79%
CELG	-1.64%
BMY		2.02%
ABT		2.53%
• View Complete Report

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar TNTY's Profile Stock Price TNTY's Financials Business Description Fundamentals Charts & Quotes TNTY's News Suppliers TNTY's Competitors Customers & Markets Economic Indicators TNTY's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Free Stock Market News Feeds

Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071

JNJ Company Profile

announced third quarter operating deficit of $-0.248187 millions

announced third quarter operating deficit of $-0.17028 millions

Logged a Loss but Revenues Unchanged

Sales and Earnings Unchanged

announced first quarter operating deficit of $-3.766026 millions